Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
GDD-3898 by Lipidio Pharmaceuticals for Dermatological Disorders: Likelihood of Approval
GDD-3898 is under clinical development by Lipidio Pharmaceuticals and currently in Phase II for Dermatological Disorders. According to GlobalData, Phase...